網膜剥離の世界市場 - 市場考察、競合情勢、市場予測（2032年）

世界の網膜剥離の市場規模は、2025年～2032年の予測期間にCAGR 6.87%で成長する見込みです。網膜剥離市場は、近視や糖尿病性網膜症のような眼疾患の急増や、老年人口の増加などにより、大きな成長が見込まれています。この動向はさらに、先進経済国と新興経済国の両方における眼科医療サービスに対する意識の高まりとアクセスの向上によって支えられています。さらに、主要企業が手術結果を向上させ、眼科医療の進化するニーズに対応するために革新的な技術に投資しており、製品開発活動への注目が高まっていることも、2025年～2032年の予測期間に網膜剥離市場全体を増大させると予測される要因の一部です。

網膜剥離の市場力学

特に若年層における近視の有病率の上昇が、網膜剥離市場の成長に大きく寄与しています。American Academy of Ophthalmology（2024）によると、中国、日本、シンガポール、韓国などの国々では、2024年にティーンエイジャーと若年成人の80%～90%が近視に罹患しており、公衆衛生上の大きな懸念として浮上している急激な増加を示しています。さらに、同じ資料は、2050年までに世界人口の半数近くが近視になると予測しており、この症状が広範囲に及ぶことを強調しています。これを補足するように、British Journal of Ophthalmology（2024）で公開された研究では、小児近視は世界の子供と青少年のおよそ3分の1が罹患しており、有病率は人口統計グループによって異なることが報告されています。2050年までに、世界の近視患者数は7億4,000万人を超えると予測されています。高度の近視は網膜剥離の確立された危険因子であることから、近視患者の継続的な急増は網膜剥離の罹患率を大幅に増加させると予測されます。近視は網膜を引き伸ばし薄くするため、網膜裂孔やそれに続く網膜剥離の影響を受けやすくなります。

さらに、政府の取り組みや眼科技術の進歩が網膜剥離治療の市場成長を促進しています。例えば、IAPBが2022年8月に実施した世界的啓発キャンペーンでは、10億人を超える治療を受けられない人々に対する眼科治療の重要性が強調されました。このような取り組みが人々の意識を高め、定期的な眼科検診と網膜問題の早期発見を促しています。これにより、OCTや眼底イメージングのような診断ツールや、硝子体手術や強膜バックリングのような外科的介入に対する需要が増加し、世界市場全体を押し上げます。

さらに、老年人口の増加が網膜剥離市場全体をさらに押し上げています。世界保健機関（WHO）（202）のデータによると、2030年までに6人に1人が60歳以上になると予測されており、世界の老年人口は2020年の10億人から14億人となり、2050年までに21億人に増加すると見込まれています。高齢者は一般的に後部硝子体剥離（PVD）を経験し、しばしば網膜裂孔や網膜原性剥離を引き起こすため、この高齢化動向は網膜剥離市場を押し上げる可能性があります。さらに、糖尿病や高血圧のような加齢に関連した慢性疾患は、牽引性網膜剥離や滲出性網膜剥離のリスクを高め、診断治療ソリューションや手術による治療ソリューションの需要をさらに促進します。

したがって、上記の要因が総合的に網膜剥離市場全体の成長を促進します。

しかし、網膜剥離手術に伴う合併症などは、網膜剥離市場にとって成長の課題となる可能性があります。

北米が網膜剥離市場全体を独占すると予測される

すべての地域の中で、北米が2024年に網膜剥離市場を独占すると予測されます。この成長の主因は、高齢化による近視と糖尿病性網膜症の増加です。その他の要因としては、確立された先進の医療インフラ、主要市場企業のプレゼンス、進行中の製品開発の取り組みなどが挙げられます。これらの要因により、予測期間に北米の網膜剥離市場の拡大が促進される見込みです。

当レポートでは、世界の網膜剥離市場について調査分析し、市場規模と予測、過去3年の製品/技術開発、市場の主要企業、利用可能な機会などの情報を提供しています。

目次

第1章 網膜剥離市場レポートのイントロダクション

第2章 網膜剥離市場のエグゼクティブサマリー

• 市場の概要

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 網膜剥離市場の主な要因の分析

• 網膜剥離市場の促進要因
• 網膜剥離市場の抑制要因と課題
• 網膜剥離市場の機会

第6章 網膜剥離市場におけるポーターのファイブフォース分析

第7章 網膜剥離市場の評価

• タイプ別
  • 裂孔原性網膜剥離
  • 牽引性網膜剥離
  • 滲出性網膜剥離
• 手術タイプ別
  • 光凝固術
  • 冷凍固定術
  • 気体網膜復位術
  • 強膜バックリング
  • 硝子体切除術
• 製品タイプ別
  • 器具
  • アクセサリ・消耗品
• エンドユーザー別
  • 病院・診療所
  • 外来手術センター
  • その他
• 地域
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 網膜剥離市場の企業と製品のプロファイル

• Carl Zeiss Meditec AG
• Meridian AG
• IRIDEX Corporation
• Ellex Medical Lasers Ltd.
• FCI
• Millennium Surgical Corp.
• BVM Medical Limited
• Lombart Instrument, Inc.
• Welch Allyn
• Baxter
• Canon Medical Systems Corporation
• Centervue SpA.
• Essilor International
• Eyenuk Inc.
• HealPros LLC
• ONL Therapeutics
• Peek Vision Ltd.
• Synergy Medical Systems LLP
• Bausch + Lomb
• STAAR Surgical

第9章 KOLの見解

第10章 プロジェクトアプローチ

第11章 DelveInsightについて

第12章 免責事項、お問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Retinal Detachment Market in Global (2022-2032)
• Table 3: Retinal Detachment Market in Global by Type (2022-2032)
• Table 4: Retinal Detachment Market in Global by Treatment Type (2022-2032)
• Table 5: Retinal Detachment Market in Global by Product Type (2022-2032)
• Table 6: Retinal Detachment Market in Global by End-User (2022-2032)
• Table 7: Retinal Detachment Market in Global by Geography (2022-2032)
• Table 8: Retinal Detachment Market in North America (2022-2032)
• Table 9: Retinal Detachment Market in the United States (2022-2032)
• Table 10: Retinal Detachment Market in Canada (2022-2032)
• Table 11: Retinal Detachment Market in Mexico (2022-2032)
• Table 12: Retinal Detachment Market in Europe (2022-2032)
• Table 13: Retinal Detachment Market in France (2022-2032)
• Table 14: Retinal Detachment Market in Germany (2022-2032)
• Table 15: Retinal Detachment Market in United Kingdom (2022-2032)
• Table 16: Retinal Detachment Market in Italy (2022-2032)
• Table 17: Retinal Detachment Market in Spain (2022-2032)
• Table 18: Retinal Detachment Market in the Rest of Europe (2022-2032)
• Table 19: Retinal Detachment Market in Asia-Pacific (2022-2032)
• Table 20: Retinal Detachment Market in China (2022-2032)
• Table 21: Retinal Detachment Market in Japan (2022-2032)
• Table 22: Retinal Detachment Market in India (2022-2032)
• Table 23: Retinal Detachment Market in Australia (2022-2032)
• Table 24: Retinal Detachment Market in South Korea (2022-2032)
• Table 25: Retinal Detachment Market in Rest of Asia-Pacific (2022-2032)
• Table 26: Retinal Detachment Market in Rest of the World (2022-2032)
• Table 27: Retinal Detachment Market in the Middle East (2022-2032)
• Table 28: Retinal Detachment Market in Africa (2022-2032)
• Table 29: Retinal Detachment Market in South America (2022-2032)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Retinal Detachment Market in Global (2022-2032)
• Figure 3: Retinal Detachment Market in Global by Type (2022-2032)
• Figure 4: Retinal Detachment Market in Global by Treatment Type (2022-2032)
• Figure 5: Retinal Detachment Market in Global by Product Type (2022-2032)
• Figure 6: Retinal Detachment Market in Global by End-User (2022-2032)
• Figure 7: Retinal Detachment Market in Global by Geography (2022-2032)
• Figure 8: Retinal Detachment Market in North America (2022-2032)
• Figure 9: Retinal Detachment Market in the United States (2022-2032)
• Figure 10: Retinal Detachment Market in Canada (2022-2032)
• Figure 11: Retinal Detachment Market in Mexico (2022-2032)
• Figure 12: Retinal Detachment Market in Europe (2022-2032)
• Figure 13: Retinal Detachment Market in France (2022-2032)
• Figure 14: Retinal Detachment Market in Germany (2022-2032)
• Figure 15: Retinal Detachment Market in United Kingdom (2022-2032)
• Figure 16: Retinal Detachment Market in Italy (2022-2032)
• Figure 17: Retinal Detachment Market in Spain (2022-2032)
• Figure 18: Retinal Detachment Market in the Rest of Europe (2022-2032)
• Figure 19: Retinal Detachment Market in Asia-Pacific (2022-2032)
• Figure 20: Retinal Detachment Market in China (2022-2032)
• Figure 21: Retinal Detachment Market in Japan (2022-2032)
• Figure 22: Retinal Detachment Market in India (2022-2032)
• Figure 23: Retinal Detachment Market in Australia (2022-2032)
• Figure 24: Retinal Detachment Market in South Korea (2022-2032)
• Figure 25: Retinal Detachment Market in Rest of Asia-Pacific (2022-2032)
• Figure 26: Retinal Detachment Market in Rest of the World (2022-2032)
• Figure 27: Retinal Detachment Market in the Middle East (2022-2032)
• Figure 28: Retinal Detachment Market in Africa (2022-2032)
• Figure 29: Retinal Detachment Market in South America (2022-2032)
• Figure 30: Market Drivers
• Figure 31: Market Barriers
• Figure 32: Marker Opportunities
• Figure 33: PORTER'S Five Force Analysis

Retinal Detachment Market by Type (Rhegmatogenous Retinal Detachment, Tractional Retinal Detachment, and Exudative Retinal Detachment), Procedure Type (Photocoagulation, Cryopexy, Pneumatic Retinopexy, Scleral Buckling, and Vitrectomy), Product Type (Instruments and Accessories & Consumables), End-User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the surge in eye disorders contributing to the increase in cases of retinal detachment, increasing awareness and access to eye care in developing countries, increase in product development activities among the key market players.

The retinal detachment market is estimated to grow at a CAGR of 6.87% during the forecast period from 2025 to 2032. The retinal detachment market is poised for significant growth due to a surge in eye disorders such as myopia and diabetic retinopathy increase in the geriatric population, among others. This trend is further supported by rising awareness and improved access to eye care services across both developed and emerging economies. Additionally, the market is witnessing a boost from the growing focus on product development activities among key players, who are investing in innovative technologies to enhance surgical outcomes and meet the evolving needs of ophthalmic care are some factors that are expected to escalate the overall retinal detachment market during the forecast period from 2025 to 2032.

Retinal Detachment Market Dynamics:

The rising prevalence of myopia, particularly among younger populations, is significantly contributing to the growth of the retinal detachment market. According to the American Academy of Ophthalmology (2024), in countries such as China, Japan, Singapore, and South Korea, as many as 80% to 90% of teenagers and young adults were affected by myopia in 2024, marking a sharp increase that has emerged as a major public health concern. The same source further projected that by 2050, nearly half of the global population will be myopic, highlighting the widespread nature of this condition. Complementing this, a study published in the British Journal of Ophthalmology (2024) reported that childhood myopia affected roughly one-third of children and adolescents globally, with prevalence rates varying across demographic groups. By 2050, the global number of myopic individuals is expected to exceed 740 million cases. Given that high myopia is a well-established risk factor for retinal detachment, the continued surge in myopia cases is anticipated to substantially increase the incidence of retinal detachment as it stretches and thins the retina, making it more susceptible to retinal tears and subsequent detachment, thereby driving demand for advanced diagnostic tools, surgical interventions, and long-term treatment solutions in the retinal detachment market.

Furthermore, government initiatives and advancements in ophthalmic technology are driving the market growth for retinal detachment treatment. For example, the IAPB's global awareness campaign in August 2022 highlighted the importance of eye care for over 1 billion people lacking treatment access. Such efforts boost public awareness, encouraging regular eye exams and early detection of retinal issues. This increases demand for diagnostic tools like OCT and fundus imaging, as well as surgical interventions such as vitrectomy and scleral buckling thereby boosting the overall market across the world.

Additionally, the increase in the aging population is further boosting the overall market of retinal detachment. According to the data provided by the World Health Organization (202), by 2030, 1 in 6 people is projected to be aged 60 or older, with the global elderly population expected to rise from 1 billion in 2020 to 1.4 billion, and to 2.1 billion by 2050. This aging trend can boost the retinal detachment market, as older adults commonly experience posterior vitreous detachment (PVD), often leading to retinal tears and rhegmatogenous retinal detachment. Additionally, age-related chronic conditions like diabetes and hypertension increase the risk of tractional and exudative retinal detachments, further driving demand for diagnostic and surgical treatment solutions.

Therefore, the factors stated above collectively will drive the overall retinal detachment market growth.

However, the complications associated with retinal detachment surgeries, and others may prove to be challenging factors for retinal detachment market growth.

Retinal Detachment Market Segment Analysis:

Retinal Detachment Market by Type (Rhegmatogenous Retinal Detachment, Tractional Retinal Detachment, and Exudative Retinal Detachment), Procedure Type (Photocoagulation, Cryopexy, Pneumatic Retinopexy, Scleral Buckling, and Vitrectomy), Product Type (Instruments and Accessories & Consumables), End-User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the retinal detachment market, the instruments category is expected to have a significant revenue share in the year 2024. The instruments category is playing a pivotal role in boosting the overall market of retinal detachment by driving innovation, improving surgical precision, and expanding the accessibility and success rates of treatment procedures. Instruments such as vitrectomy systems, retinal forceps, micro scissors, illumination probes, laser photocoagulators, and trocar cannulas have become essential tools in the surgical management of retinal detachment. These advanced tools allow ophthalmic surgeons to perform complex procedures such as pars plana vitrectomy, scleral buckling, and pneumatic retinopexy with greater control, reduced surgical time, and minimal trauma to ocular tissues. The availability of minimally invasive and micro-incision surgical instruments has enhanced patient recovery outcomes and encouraged the adoption of these procedures globally, especially in outpatient and ambulatory settings.

Technological improvements in instrument ergonomics, gauge systems (like 25G and 27G), and integrated visualization systems have significantly enhanced the precision and efficiency of retinal detachment surgeries. For instance, high-speed vitrectomy cutters and endoillumination systems improve the safety of procedures by offering clearer visualization of the retina, enabling surgeons to address even subtle retinal tears or detachments. Moreover, the integration of fluidics control digitally assisted visualization, and multifunctional probes in surgical platforms has allowed for better management of complex detachments, including those caused by trauma or diabetic retinopathy. For example, Alcon Constellation(R) Vision System, integrates advanced fluidics control, high-speed vitrectomy cutting, illuminated visualization, and multi-functional dual-mode probes into a single surgical platform. These advancements not only improve surgical outcomes but also reduce the risk of complications and recurrence, making surgery more appealing to both patients and providers. Additionally, in April 2025, Alcon, a global leader in eye care committed to helping people see brilliantly, announced the launch of its UNITY(R) Vitreoretinal Cataract System (VCS) and UNITY(R) Cataract System (CS).

Overall, the instruments category is expected to boost the overall market of retinal detachment during the forecast period from 2025 to 2032.

North America is expected to dominate the overall retinal detachment market:

Among all the regions, North America is expected to dominate the retinal detachment market in the year 2024. This growth is primarily driven by the rising cases of myopia and diabetic retinopathy, largely due to an aging population. Additional contributing factors include a well-established and advanced healthcare infrastructure, the strong presence of key market players, and ongoing product development initiatives. Collectively, these factors are expected to propel the expansion of the retinal detachment market across the North American region during the forecast period.

According to the data provided by the Centers for Disease Control and Prevention (CDC) (2023), in 2021, it was estimated that in the United States, around 9.6 million people with diabetes, or 2.6%, had diabetic retinopathy (DR), and 1.84 million, or 5.1% of those with diabetes, had vision-threatening diabetic retinopathy (VTDR).

Additionally, as per the same source, in 2021, an estimated 9.6 million people in the U.S. were living with diabetic retinopathy (DR), including 1.84 million with vision-threatening DR. Among individuals with diabetes, the lowest DR prevalence was observed in those under 25 years (13.0%) and the highest in the 65-79 age group (28.4%). Additionally, 8.94 million people aged 40 and above had DR, and 1.71 million in this age group had vision-threatening DR. Thus, the growing prevalence of diabetic retinopathy and its progression to vision-threatening stages is driving the market for retinal detachment treatments. As diabetic complications damage the retina, the demand for advanced surgical interventions, diagnostic tools, and preventive therapies increases, supporting the expansion of the retinal detachment market in the healthcare sector.

The well-established healthcare services and infrastructure further contribute to the growth of the regional retinal detachment market growth. The presence of key players such as Carl Zeiss Meditec AG, IRIDEX Corporation, FCI, and Bausch + Lomb among others with their strong distribution networks ensure widespread availability and accessibility of these devices across the region increasing their revenue shares in the market, and supportive reimbursement programs providing immense growth opportunities for the same.

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North America retinal detachment market.

Retinal Detachment Market Key Players:

Some of the key market players operating in the retinal detachment market include Carl Zeiss Meditec AG, Meridian AG, IRIDEX Corporation, Ellex Medical Lasers Ltd., FCI, Millennium Surgical Corp., BVM Medical Limited, Lombart Instrument, Inc., Welch Allyn, Baxter, Canon Medical Systems Corporation, Centervue SpA., Essilor International, Eyenuk Inc., HealPros LLC, ONL Therapeutics, Peek Vision Ltd., Synergy Medical Systems LLP, Bausch + Lomb, STAAR Surgical, and others.

Recent Developmental Activities in the Retinal Detachment Market:

• In May 2023, Norlase, a leading global ophthalmic laser manufacturer developing next-generation laser solutions, announced that it had received both FDA 510(k) clearance and CE Mark approval for the ECHO Green Pattern Laser photocoagulator.

Key takeaways from the retinal detachment market report study:

• Market size analysis for current retinal detachment market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the retinal detachment market.
• Various opportunities available for the other competitors in the retinal detachment market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current retinal detachment market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for retinal detachment market growth in the coming future?

Target audience who can benefit from this retinal detachment market report study:

• Retinal detachment product providers
• Research organizations and consulting companies
• Retinal detachment-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in retinal detachment
• Various end-users who want to know more about the retinal detachment market and the latest technological developments in the retinal detachment market.

Frequently Asked Questions for the Retinal Detachment Market:

1. What is retinal detachment?

• Retinal detachment is a serious eye condition where the retina, the thin layer of tissue at the back of the eye, separates from its underlying supportive tissue. This separation prevents the retina from functioning properly, potentially leading to vision loss if not treated promptly.

2. What is the market for retinal detachment?

• The retinal detachment market is estimated to grow at a CAGR of 6.87% during the forecast period from 2025 to 2032.

3. What are the drivers for the retinal detachment market?

• The retinal detachment market is poised for significant growth due to a surge in eye health complications that led to an increasing volume of surgical procedures in ophthalmology. This trend is further supported by rising awareness and improved access to eye care services across both developed and emerging economies. Additionally, the market is witnessing a boost from the growing focus on product development activities among key players, who are investing in innovative technologies to enhance surgical outcomes and meet the evolving needs of ophthalmic care are some factors that are expected to escalate the overall retinal detachment market during the forecast period from 2025 to 2032.

4. Who are the key players operating in the retinal detachment market?

• Some of the key market players operating in retinal detachment include Carl Zeiss Meditec AG, Meridian AG, IRIDEX Corporation, Ellex Medical Lasers Ltd, FCI, Millennium Surgical Corp., BVM Medical Limited, Lombart Instrument, Inc., Welch Allyn, Baxter, Canon Medical Systems Corporation, Centervue SpA., Essilor International, Eyenuk Inc., HealPros LLC, ONL Therapeutics, Peek Vision Ltd., Synergy Medical Systems LLP, Bausch + Lomb, STAAR Surgical, and others.

5. Which region has the highest share in the retinal detachment market?

• Among all the regions, North America is expected to dominate the retinal detachment market in the year 2024. This growth is primarily driven by the rising cases of myopia and diabetic retinopathy, largely due to an aging population. Additional contributing factors include a well-established and advanced healthcare infrastructure, the strong presence of key market players, and ongoing product development initiatives. Collectively, these factors are expected to propel the expansion of the retinal detachment market across the North American region during the forecast period.

Table of Contents

1. Retinal Detachment Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Retinal Detachment Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Retinal Detachment Market Key Factors Analysis

• 5.1. Retinal Detachment Market Drivers
  • 5.1.1. The rising cases of eye disorders and their associated risk factors
  • 5.1.2. Increasing awareness and access to eye care in developing countries
  • 5.1.3. Increase in product development activities in the market
• 5.2. Retinal Detachment Market Restraints and Challenges
  • 5.2.1. Complications associated with retinal detachment surgeries
• 5.3. Retinal Detachment Market Opportunity
  • 5.3.1. Integration of AI-guided tools during surgery

6. Retinal Detachment Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Retinal Detachment Market Assessment

• 7.1. By Type
  • 7.1.1. Rhegmatogenous Retinal Detachment
  • 7.1.2. Tractional Retinal Detachment
  • 7.1.3. Exudative Retinal Detachment
• 7.2. By Procedure Type
  • 7.2.1. Photocoagulation
  • 7.2.2. Cryopexy
  • 7.2.3. Pneumatic Retinopexy
  • 7.2.4. Scleral Buckling
  • 7.2.5. Vitrectomy
• 7.3. By Product Type
  • 7.3.1. Instruments
  • 7.3.2. Accessories & Consumables
• 7.4. By End-User
  • 7.4.1. Hospitals and Clinics
  • 7.4.2. Ambulatory Surgical Centers
  • 7.4.3. Others
• 7.5. By Geography
  • 7.5.1. North America
    • 7.5.1.1. United States Retinal Detachment Market Size in USD million (2022-2032)
    • 7.5.1.2. Canada Retinal Detachment Market Size in USD million (2022-2032)
    • 7.5.1.3. Mexico Retinal Detachment Market Size in USD million (2022-2032)
  • 7.5.2. Europe
    • 7.5.2.1. France Retinal Detachment Market Size in USD million (2022-2032)
    • 7.5.2.2. Germany Retinal Detachment Market Size in USD million (2022-2032)
    • 7.5.2.3. United Kingdom Retinal Detachment Market Size in USD million (2022-2032)
    • 7.5.2.4. Italy Retinal Detachment Market Size in USD million (2022-2032)
    • 7.5.2.5. Spain Retinal Detachment Market Size in USD million (2022-2032)
    • 7.5.2.6. Rest of Europe Retinal Detachment Market Size in USD million (2022-2032)
  • 7.5.3. Asia-Pacific
    • 7.5.3.1. China Retinal Detachment Market Size in USD million (2022-2032)
    • 7.5.3.2. Japan Retinal Detachment Market Size in USD million (2022-2032)
    • 7.5.3.3. India Retinal Detachment Market Size in USD million (2022-2032)
    • 7.5.3.4. Australia Retinal Detachment Market Size in USD million (2022-2032)
    • 7.5.3.5. South Korea Retinal Detachment Market Size in USD million (2022-2032)
    • 7.5.3.6. Rest of Asia-Pacific Retinal Detachment Market Size in USD million (2022-2032)
  • 7.5.4. Rest of the World (RoW)
    • 7.5.4.1. Middle East Retinal Detachment Market Size in USD million (2022-2032)
    • 7.5.4.2. Africa Retinal Detachment Market Size in USD million (2022-2032)
    • 7.5.4.3. South America Retinal Detachment Market Size in USD million (2022-2032)

8. Retinal Detachment Market Company and Product Profiles

• 8.1. Carl Zeiss Meditec AG
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Meridian AG
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. IRIDEX Corporation
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Ellex Medical Lasers Ltd.
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. FCI
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Millennium Surgical Corp.
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. BVM Medical Limited
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Lombart Instrument, Inc.
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Welch Allyn
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Baxter
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Canon Medical Systems Corporation
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Centervue SpA.
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Essilor International
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Eyenuk Inc.
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. HealPros LLC
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. ONL Therapeutics
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. Peek Vision Ltd.
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. Synergy Medical Systems LLP
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Bausch + Lomb
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. STAAR Surgical
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us